Future PLC
17 January 2008
The following amendment has been made to the Director/PDMR Shareholding
announcement released on 16/01/08 at 16:36 under RNS No 9332L.
Stevie Spring's total beneficial interest in shares is 439,397 shares, which
represents 0.13% of the Company's issued share capital.
All other details remain unchanged.
The full amended text is shown below.
FUTURE PLC
DIRECTORS'/PDMRs INTERESTS IN SHARES - AMENDMENT
Future plc (the 'Company'), the international special-interest media group,
announces that it received notification in accordance with DTR 3.1.2 R on 15
January 2008 from Abacus Corporate Trustee Limited, the Trustee of the Company's
Employee Benefit Trust (the 'Trust'), of a change in its holding of the
Company's ordinary shares of 1p each.
On 9 January 2008, the Trust transferred to individuals (including the executive
Directors referred to below) a total of 533,291 shares, representing 0.16% of
the issued share capital of the Company, being the balance of shares which had
vested, less the number of shares sold to meet the tax and NI liability arising
on the vesting of such shares.
In order to meet the tax and NI liability arising on the vesting, on 9 January
2008, the Trust sold 317,156 shares in the Company (at a gross average price of
35.5p per share), representing 0.09% of the issued share capital of the Company.
As a result of the vesting of one-third of her Restricted Stock Award on 31
December 2007, Stevie Spring's beneficial interest in shares of the Company has
increased by 155,796 (comprising the vesting of 248,447 of her Restricted Stock
Award shares less the sale of 92,651 of those shares at a price of 35.5p per
share on 9 January 2008 by the Trust in order to meet the tax liability arising
on the vesting of the Award). Stevie Spring has undertaken not, without the
consent of the board of the Company, to dispose of any shares that vest under
the Restricted Stock Award (other than any sold to pay the tax and NI liability
that arises on vesting) while she remains employed with the Company. Stevie
Spring's total beneficial interest in shares is 439,397 shares, which represents
0.13% of the Company's issued share capital.
As a result of the vesting of one-third of his Restricted Stock Award on 31
December 2007, John Bowman's beneficial interest in shares of the Company has
increased by 62,708 (comprising the vesting of 100,000 of his Restricted Stock
Award shares less the sale of 37,292 of those shares at a price of 35.5p per
share on 9 January 2008 by the Trust in order to meet the tax liability arising
on the vesting of the Award). John Bowman has undertaken not, without the
consent of the board of the Company, to dispose of any shares that vest under
the Restricted Stock Award (other than any sold to pay the tax and NI liability
that arises on vesting) while he remains employed with the Company. John
Bowman's total beneficial interest in shares is 752,309 shares, which represents
0.23% of the Company's issued share capital.
ENDS
Enquiries:
Future plc
Mark Millar, Company Secretary 01225 442244
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.